Ophthalmic manifestations of systemic disease: Viva

This is a branching oral built to probe the reasoning that holds the silent uveitis and the screening schedule at the centre, and to expose the candidate who has memorised the headline without the safety-critical corners. The questions escalate from the framing of the ophthalmic risk to the screening schedule, the stepwise treatment, and the contrast with the diabetes, the neurofibromatosis and the metabolic eye signs, with deliberate probes into the red flags and the global child health. ^[1]

Opening question: framing the ophthalmic risk

The examiner opens with the swollen knee and the positive antinuclear antibody and asks: what is the ophthalmic risk in this child, and what is your first step? ^[1]

A strong answer names the chronic anterior uveitis of the juvenile idiopathic arthritis as the sight-threatening silent inflammation, and states that the first step is the slit-lamp screening by the ophthalmology service at the high-risk interval. ^[1]

Model answer. This child carries the highest risk of the chronic anterior uveitis of any child in the clinic, because the oligoarticular antinuclear-antibody-positive disease in the young child is the profile that carries the uveitis in the greatest proportion, yet the uveitis is silent and produces no eye symptom. The first step is the slit-lamp screening by the ophthalmology service at the every-three-months interval, because the slit-lamp is the only detection of the cells and the flare before they scar the anterior chamber. ^[1]

Probe one: the screening schedule